2013 Aspirin Foundation Meeting

Prof Peter Elwood talks to ecancer at the 2013 Aspirin Foundation meeting in Oxford about early clinical trials looking at aspirin and recent discoveries on its uses in cancer treatment. Prof Elwood’s two talks at the meeting were on the history of aspirin and the transition from the original use against headaches and, later, heart problems and how cancer reduces the spread of cancer.

Dr Andrew Freedman talks to ecancer at the 2013 Aspirin Foundation meeting in Oxford about the use of aspirin in aiding the treatment of vascular diseases in patients with HIV.

Dr Andrea De Censi talks to ecancer at the 2013 Aspirin Foundation meeting in Oxford about using aspirin to prevent of a number of cancers and their subtypes, including colorectal and lung cancer.

Prof Peter Rothwell talks to ecancer at the 2013 Aspirin Foundation meeting in Oxford about the current state of treating cancer with aspirin. The two main aspects of current research are the short-term effect on growth and metastasis and the long-term effect of preventing the growth of new cancers.

The executive director of the Aspirin Foundation, Nick Henderson, discusses the progress made in the discovery of uses for the drug, as well as the history of the foundation and its meetings.

Dr Tom Smith talks to ecancer at the 2013 Aspirin Foundation meeting in Oxford about how aspirin is used by general practitioners and its future uses.

Prof Richard Logan talks to ecancer at the 2013 Aspirin Foundation meeting in Oxford about chemoprevention in bladder cancer and screening programmes across the UK and Europe.

Prof Ceri Phillips talks to ecancer at the 2013 Aspirin Foundation meeting in Oxford about the importance of using aspirin in primary prevention treatment of CHD and CVD. Prof Phillips also discusses the cost benefits of using aspirin and the importance this plays in selecting other treatment methods.

Dr Conrad Keating talks to ecancer at the 2013 Aspirin Foundation meeting in Oxford about the ISIS-2 study, which examined the use of aspirin in preventing heart attacks and additional cardiovascular problems.